Axonally Transported Peripheral Signals Regulate Alpha-internexin Expression in Regenerating Motoneurons
Overview
Affiliations
The class IV neuronal intermediate filament (IF) family proteins includes the neurofilament (NF) triplet proteins NF-L, NF-M, and NF-H and also the more recently characterized alpha-internexin-NF66. It is well established that NF-L, -M, and -H protein and mRNA are downregulated after peripheral nerve injury. We examined alpha-internexin protein expression after three facial nerve lesion paradigms: crush, transection, and resection. Alpha-internexin immunoreactivity was absent in the perikarya of uninjured facial motoneurons but increased dramatically in all three injury paradigms, with maximum immunoreactivity observed at 7 d after injury. Twenty-eight days after nerve crush or transection, there was a dramatic decrease in the number of alpha-internexin-positive cells. In contrast, alpha-internexin remained elevated 28 d after nerve resection, an injury that hinders regeneration and target reinnervation. In situ hybridization studies showed an increase in alpha-internexin mRNA expression in the facial nucleus at 7 and 14 d after injury. Retrograde transport of fluorogold from the whisker pads to the facial nucleus was seen only in motoneurons that lacked alpha-internexin immunoreactivity, supporting the idea that target reinnervation and inhibitory signals from the periphery regulate the expression of alpha-internexin. Blockage of axonal transport through local colchicine application induced strong immunoreactivity in motoneurons. Alpha-internexin expression was also examined after central axotomy of rubrospinal neurons, which constitutively show alpha-internexin immunoreactivity. After rubrospinal tractotomy, alpha-internexin immunoreactivity transiently increased by 7 d after injury but returned to control levels by 14 d. We conclude that alpha-internexin upregulation in injured motoneurons suggests a role for this IF protein in neuronal regeneration.
Posttranscriptional regulation of neurofilament proteins and tau in health and disease.
Yuan A, Nixon R Brain Res Bull. 2022; 192:115-127.
PMID: 36441047 PMC: 9907725. DOI: 10.1016/j.brainresbull.2022.10.017.
Garcia-Cruz C, Merino-Jimenez C, Aragon J, Ceja V, Gonzalez-Assad B, Reyes-Grajeda J Sci Rep. 2022; 12(1):1410.
PMID: 35082358 PMC: 8791958. DOI: 10.1038/s41598-022-05271-2.
A Global Multiregional Proteomic Map of the Human Cerebral Cortex.
Guo Z, Shao C, Zhang Y, Qiu W, Li W, Zhu W Genomics Proteomics Bioinformatics. 2021; 20(4):614-632.
PMID: 34763096 PMC: 9880820. DOI: 10.1016/j.gpb.2021.08.008.
Nakamura M, Bieniek K, Lin W, Graff-Radford N, Murray M, Castanedes-Casey M Acta Neuropathol. 2015; 130(1):145-57.
PMID: 25917047 PMC: 5039014. DOI: 10.1007/s00401-015-1431-2.
Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease.
Zali H, Zamanian-Azodi M, Rezaei Tavirani M, Akbar-Zadeh Baghban A Iran J Pharm Res. 2015; 14(1):291-302.
PMID: 25561935 PMC: 4277642.